wire - news in brief
Category
- Academic Rankings
- Administration
- Agronomy/Food Science
- Architecture
- Astronomy/Space Science
- Business/Economics
- Careers/Employment
- Chemistry
- Civil Engineering
- Computer Science/Telecom
- Continuing Education
- Earth Sciences
- Environment
- Event
- Health
- Innovation/Technology
- Life Sciences
- Literature/Linguistics
Results 301 - 327 of 327.
Huge systems of rotating water masses - called gyres - form in oceans and large lakes. Two EPFL laboratories, working with the University of California, Davis, are using an underwater glider to explore one such gyre in Lake Geneva and learn more about how it affects the three-dimensional structure of the aquatic ecosystem.
ESA Earth Observation Mission: Aeolus measures the wind
Bern, 20.08.2018 - On 21 August 2018, the European Space Agency (ESA) will launch the scientific Earth observation mission Aeolus. The aim of the mission is the global mapping of wind profiles in the atmosphere. These observations, together with information about aerosols and clouds, contribute to an improved understanding of the dynamic processes in the atmosphere and are of great importance for weather forecasting.
Bern, 20.08.2018 - On 21 August 2018, the European Space Agency (ESA) will launch the scientific Earth observation mission Aeolus. The aim of the mission is the global mapping of wind profiles in the atmosphere. These observations, together with information about aerosols and clouds, contribute to an improved understanding of the dynamic processes in the atmosphere and are of great importance for weather forecasting.
China National Drug Administration grants rapid approval of Roche’s Alecensa (alectinib) as a treatment for ALK-positive lung cancer
China National Drug Administration grants rapid approval of Roche's Alecensa (alectinib) as a treatment for ALK-positive lung cancer Approval follows priority review of Alecensa in China, just eight
China National Drug Administration grants rapid approval of Roche's Alecensa (alectinib) as a treatment for ALK-positive lung cancer Approval follows priority review of Alecensa in China, just eight
Annelen Kahl, a post-doc in environmental sciences and engineering at EPFL, will oversee a group of four EPFL students during a three-week stint at a high-tech research station on a Siberian island.
Four Million Euros Awarded to Three UZH Researchers
Three scientists of the University of Zurich have been awarded the EU's coveted ERC Starting Grants.
Three scientists of the University of Zurich have been awarded the EU's coveted ERC Starting Grants.
PRIME designation granted by European Medicines Agency for RG6042 for treatment of Huntington’s disease
European Medicines Agency PRIME (PRIority MEdicines) status is granted to medicines that may offer a major therapeutic advantage over existing treatments, or benefit patients without treatment options RG6042 has the potential to be the first therapy targeting the underlying cause of Huntington's disease, a fatal neurodegenerative rare disease Third PRIME designation for a Roche medicine Roche today announced that the European Medicines Agency (E
European Medicines Agency PRIME (PRIority MEdicines) status is granted to medicines that may offer a major therapeutic advantage over existing treatments, or benefit patients without treatment options RG6042 has the potential to be the first therapy targeting the underlying cause of Huntington's disease, a fatal neurodegenerative rare disease Third PRIME designation for a Roche medicine Roche today announced that the European Medicines Agency (E
Eawag, the ETH Zurich and the University of Bern have developed a new instrument: the "Combined Vacuum Crushing and Sieving System" (CVCS). This device makes possible the extraction of minute water and noble gas inclusions that are thousands of years old from the pores of minerals in caves, without distortion by the present atmosphere.
Novartis marks a new era for migraine patients with the EU approval of Aimovig , a first-of-its-kind treatment specifically designed for migraine prevention
Novartis marks a new era for migraine patients with the EU approval of Aimovig , a first-of-its-kind treatment specifically designed for migraine prevention Patients on Aimovig (erenumab) in clinical
Novartis marks a new era for migraine patients with the EU approval of Aimovig , a first-of-its-kind treatment specifically designed for migraine prevention Patients on Aimovig (erenumab) in clinical
Researchers at ETH Zurich have fabricated an 80 m2 lightweight concrete slab at the DFAB House, making it the world's first full-scale architectural project to use 3D sand printing for its formwork.
Knowledge brokering is a technical term used to describe activities to facilitate mutual learning between researchers, practitioners and policy makers.
Novartis combination Tafinlar + Mekinist receives positive CHMP opinion for adjuvant treatment of BRAF V600 mutation-positive melanoma
Phase III trial showed a 53% reduction in risk of recurrence or death with the combination of a BRAF and MEK inhibitor as adjuvant therapy versus placebo Relapse-free survival benefit with Tafinlar
Phase III trial showed a 53% reduction in risk of recurrence or death with the combination of a BRAF and MEK inhibitor as adjuvant therapy versus placebo Relapse-free survival benefit with Tafinlar
A workshop was held on 16 to 20 July in Basel, Switzerland, bringing together over 60 Swiss TPH employees including 37 from 14 countries in West and Central Africa and the Middle East.
Scientists set out to explore microbial life in glacier streams
EPFL scientists will spend at least the next four years studying some of the world's biggest glacier-fed streams.
EPFL scientists will spend at least the next four years studying some of the world's biggest glacier-fed streams.